Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01251068
Other study ID # 1
Secondary ID
Status Recruiting
Phase N/A
First received November 30, 2010
Last updated December 6, 2010
Start date December 2010
Est. completion date June 2011

Study information

Verified date November 2010
Source Zekai Tahir Burak Women's Health Research and Education Hospital
Contact gonca sandal, MD
Phone 05054871028
Email kocabasgonca@mynet.com
Is FDA regulated No
Health authority Turkey: Ethics Committee
Study type Interventional

Clinical Trial Summary

Near infrared spectroscopy offers the possibility of noninvasive and continuous bedside investigation of cerebral oxygenation in newborn infants. Using this technique we investigated the relationship between changes in cerebral oxygenation and hemodynamics, and changes in some physiological variables during blood transfusion in anaemic preterm infants.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date June 2011
Est. primary completion date June 2011
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria: <32 gestational age and/or <1500gr.,>30th day preterm infants -

Exclusion Criteria:sepsis,shock,severe intracranial hemorrhage,NEC,abdominal and cranial surgery

Study Design

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms

  • Anemic Preterms, Cerebral Oxygenation,Somatic Oxygenation,Blood Transfusion
  • Premature Birth

Intervention

Device:
near infrared spectroscopy: invos 5100
duration:six hours
INVOS 5100
NIRS device used in this study, the optical field includes a volume of tissue approximately 2 cm deep to the surface probe with a 4-mm source-detector distance, and thus, organ-specific monitoring is feasible in small patients. With informed consent, we applied NIRS probes to the forehead and the lower extremity for cerebral (rSO2C) and peripheric (rSO2P) regional oxygen saturation measurements.
near infrared spectroscopy device
NIRS device used in this study, the optical field includes a volume of tissue approximately 2 cm deep to the surface probe with a 4-mm source-detector distance, and thus, organ-specific monitoring is feasible in small patients. With informed consent, we applied NIRS probes to the forehead and the lower extremity for cerebral (rSO2C) and peripheric (rSO2P) regional oxygen saturation measurements.

Locations

Country Name City State
Turkey Zekai Tahir Maternity Teaching Hospital Ankara Hamamönü
Turkey Zekai Tahir Maternity Teaching Hospital Ankara Hamamönü

Sponsors (1)

Lead Sponsor Collaborator
Zekai Tahir Burak Women's Health Research and Education Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cerebral and peripheric oxygenation measurements in anemic preterm infants. 6 months No